This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
Diphtheria-tetanus-acellular pertussis booster vaccination programmes (to achieve coverage levels varying from 25% to 95%) were compared with no vaccination programme in neonatal intensive care unit healthcare workers. Staff were assumed to receive the booster at baseline. As staff were lost and replaced, they received the vaccination according to the coverage in the baseline vaccine programme.
Location/setting
Canada/secondary care
Methods

Analytical approach:
The authors used a 10 year Markov model with one month cycles to simulate transmission of nosocomial pertussis in a neonatal intensive care unit environment. The authors stated that the model perspective was a modified societal perspective.
Effectiveness data:
The clinical evidence came from a selection of studies from the published literature, and the results of an agent-based model of pertussis transmission (Greer 2009, see Other publications of related interest) in a neonatal intensive care unit.
The key clinical effectiveness estimates were the transmission rates of pertussis from a staff member with pertussis and the consequences of infection. These estimates came from the agent-based model.
Monetary benefit and utility valuations:
Utility values were estimated for parents and children from published literature. Maternal and paternal utilities decreased if a child died and were further decreased if a child survived but had a neurologic disability. Utilities for children were estimated using average Canadian life expectancies modified by level of neurologic disability.
Measure of benefit:
Quality-adjusted life-years (QALYs) were the summary measure of benefit. Future benefits were discounted at a rate of 3% per year.
